nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—Phlebitis—Carboplatin—bone cancer	0.0654	0.0654	CcSEcCtD
Cefotetan—Nephropathy toxic—Cisplatin—bone cancer	0.0397	0.0397	CcSEcCtD
Cefotetan—Prothrombin level increased—Epirubicin—bone cancer	0.0285	0.0285	CcSEcCtD
Cefotetan—Prothrombin level increased—Doxorubicin—bone cancer	0.0264	0.0264	CcSEcCtD
Cefotetan—Vaginal moniliasis—Epirubicin—bone cancer	0.0232	0.0232	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Epirubicin—bone cancer	0.0223	0.0223	CcSEcCtD
Cefotetan—Body temperature increased—Carboplatin—bone cancer	0.0219	0.0219	CcSEcCtD
Cefotetan—Vaginal moniliasis—Doxorubicin—bone cancer	0.0214	0.0214	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Epirubicin—bone cancer	0.0214	0.0214	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Doxorubicin—bone cancer	0.0206	0.0206	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Doxorubicin—bone cancer	0.0198	0.0198	CcSEcCtD
Cefotetan—Phlebitis—Cisplatin—bone cancer	0.0192	0.0192	CcSEcCtD
Cefotetan—Thrombocytosis—Epirubicin—bone cancer	0.0188	0.0188	CcSEcCtD
Cefotetan—Haemolytic anaemia—Cisplatin—bone cancer	0.0183	0.0183	CcSEcCtD
Cefotetan—Thrombocytosis—Doxorubicin—bone cancer	0.0174	0.0174	CcSEcCtD
Cefotetan—Pancytopenia—Cisplatin—bone cancer	0.0136	0.0136	CcSEcCtD
Cefotetan—Vaginal inflammation—Methotrexate—bone cancer	0.0125	0.0125	CcSEcCtD
Cefotetan—Blood bilirubin increased—Epirubicin—bone cancer	0.0124	0.0124	CcSEcCtD
Cefotetan—Vaginal infection—Methotrexate—bone cancer	0.0118	0.0118	CcSEcCtD
Cefotetan—Aplastic anaemia—Methotrexate—bone cancer	0.0117	0.0117	CcSEcCtD
Cefotetan—Vaginal inflammation—Epirubicin—bone cancer	0.0117	0.0117	CcSEcCtD
Cefotetan—Blood bilirubin increased—Doxorubicin—bone cancer	0.0114	0.0114	CcSEcCtD
Cefotetan—Colitis—Epirubicin—bone cancer	0.0112	0.0112	CcSEcCtD
Cefotetan—Vaginal infection—Epirubicin—bone cancer	0.011	0.011	CcSEcCtD
Cefotetan—Aplastic anaemia—Epirubicin—bone cancer	0.011	0.011	CcSEcCtD
Cefotetan—Vaginal inflammation—Doxorubicin—bone cancer	0.0108	0.0108	CcSEcCtD
Cefotetan—Colitis—Doxorubicin—bone cancer	0.0104	0.0104	CcSEcCtD
Cefotetan—Vaginal infection—Doxorubicin—bone cancer	0.0102	0.0102	CcSEcCtD
Cefotetan—Aplastic anaemia—Doxorubicin—bone cancer	0.0102	0.0102	CcSEcCtD
Cefotetan—Phlebitis—Epirubicin—bone cancer	0.00986	0.00986	CcSEcCtD
Cefotetan—Hepatic function abnormal—Epirubicin—bone cancer	0.00972	0.00972	CcSEcCtD
Cefotetan—Phlebitis—Doxorubicin—bone cancer	0.00912	0.00912	CcSEcCtD
Cefotetan—Hepatic function abnormal—Doxorubicin—bone cancer	0.00899	0.00899	CcSEcCtD
Cefotetan—Leukopenia—Cisplatin—bone cancer	0.00891	0.00891	CcSEcCtD
Cefotetan—Convulsion—Cisplatin—bone cancer	0.00863	0.00863	CcSEcCtD
Cefotetan—Discomfort—Cisplatin—bone cancer	0.00838	0.00838	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00817	0.00817	CcSEcCtD
Cefotetan—Anaphylactic shock—Cisplatin—bone cancer	0.00813	0.00813	CcSEcCtD
Cefotetan—Thrombocytopenia—Cisplatin—bone cancer	0.00796	0.00796	CcSEcCtD
Cefotetan—Eosinophilia—Methotrexate—bone cancer	0.00777	0.00777	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00765	0.00765	CcSEcCtD
Cefotetan—Pancytopenia—Methotrexate—bone cancer	0.00745	0.00745	CcSEcCtD
Cefotetan—Neutropenia—Methotrexate—bone cancer	0.00733	0.00733	CcSEcCtD
Cefotetan—Eosinophilia—Epirubicin—bone cancer	0.00727	0.00727	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00708	0.00708	CcSEcCtD
Cefotetan—Pancytopenia—Epirubicin—bone cancer	0.00697	0.00697	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00693	0.00693	CcSEcCtD
Cefotetan—Neutropenia—Epirubicin—bone cancer	0.00686	0.00686	CcSEcCtD
Cefotetan—Eosinophilia—Doxorubicin—bone cancer	0.00672	0.00672	CcSEcCtD
Cefotetan—Agranulocytosis—Methotrexate—bone cancer	0.00653	0.00653	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00649	0.00649	CcSEcCtD
Cefotetan—Pancytopenia—Doxorubicin—bone cancer	0.00645	0.00645	CcSEcCtD
Cefotetan—Body temperature increased—Cisplatin—bone cancer	0.00643	0.00643	CcSEcCtD
Cefotetan—Neutropenia—Doxorubicin—bone cancer	0.00635	0.00635	CcSEcCtD
Cefotetan—Haemoglobin—Methotrexate—bone cancer	0.00631	0.00631	CcSEcCtD
Cefotetan—Haemorrhage—Methotrexate—bone cancer	0.00628	0.00628	CcSEcCtD
Cefotetan—Agranulocytosis—Epirubicin—bone cancer	0.00611	0.00611	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.006	0.006	CcSEcCtD
Cefotetan—Hypersensitivity—Cisplatin—bone cancer	0.00599	0.00599	CcSEcCtD
Cefotetan—Erythema multiforme—Methotrexate—bone cancer	0.00594	0.00594	CcSEcCtD
Cefotetan—Haemoglobin—Epirubicin—bone cancer	0.0059	0.0059	CcSEcCtD
Cefotetan—Haemorrhage—Epirubicin—bone cancer	0.00587	0.00587	CcSEcCtD
Cefotetan—Agranulocytosis—Doxorubicin—bone cancer	0.00565	0.00565	CcSEcCtD
Cefotetan—Diarrhoea—Cisplatin—bone cancer	0.00556	0.00556	CcSEcCtD
Cefotetan—Erythema multiforme—Epirubicin—bone cancer	0.00555	0.00555	CcSEcCtD
Cefotetan—Haemoglobin—Doxorubicin—bone cancer	0.00546	0.00546	CcSEcCtD
Cefotetan—Haemorrhage—Doxorubicin—bone cancer	0.00544	0.00544	CcSEcCtD
Cefotetan—Vomiting—Cisplatin—bone cancer	0.00517	0.00517	CcSEcCtD
Cefotetan—Erythema multiforme—Doxorubicin—bone cancer	0.00514	0.00514	CcSEcCtD
Cefotetan—Rash—Cisplatin—bone cancer	0.00512	0.00512	CcSEcCtD
Cefotetan—Dermatitis—Cisplatin—bone cancer	0.00512	0.00512	CcSEcCtD
Cefotetan—Leukopenia—Methotrexate—bone cancer	0.00489	0.00489	CcSEcCtD
Cefotetan—Nausea—Cisplatin—bone cancer	0.00483	0.00483	CcSEcCtD
Cefotetan—Convulsion—Methotrexate—bone cancer	0.00473	0.00473	CcSEcCtD
Cefotetan—Discomfort—Methotrexate—bone cancer	0.0046	0.0046	CcSEcCtD
Cefotetan—Leukopenia—Epirubicin—bone cancer	0.00458	0.00458	CcSEcCtD
Cefotetan—Anaphylactic shock—Methotrexate—bone cancer	0.00446	0.00446	CcSEcCtD
Cefotetan—Convulsion—Epirubicin—bone cancer	0.00443	0.00443	CcSEcCtD
Cefotetan—Thrombocytopenia—Methotrexate—bone cancer	0.00437	0.00437	CcSEcCtD
Cefotetan—Discomfort—Epirubicin—bone cancer	0.0043	0.0043	CcSEcCtD
Cefotetan—Leukopenia—Doxorubicin—bone cancer	0.00424	0.00424	CcSEcCtD
Cefotetan—Anaphylactic shock—Epirubicin—bone cancer	0.00417	0.00417	CcSEcCtD
Cefotetan—Convulsion—Doxorubicin—bone cancer	0.0041	0.0041	CcSEcCtD
Cefotetan—Thrombocytopenia—Epirubicin—bone cancer	0.00409	0.00409	CcSEcCtD
Cefotetan—Discomfort—Doxorubicin—bone cancer	0.00398	0.00398	CcSEcCtD
Cefotetan—Anaphylactic shock—Doxorubicin—bone cancer	0.00386	0.00386	CcSEcCtD
Cefotetan—Thrombocytopenia—Doxorubicin—bone cancer	0.00378	0.00378	CcSEcCtD
Cefotetan—Gastrointestinal pain—Methotrexate—bone cancer	0.00365	0.00365	CcSEcCtD
Cefotetan—Urticaria—Methotrexate—bone cancer	0.00354	0.00354	CcSEcCtD
Cefotetan—Body temperature increased—Methotrexate—bone cancer	0.00353	0.00353	CcSEcCtD
Cefotetan—Abdominal pain—Methotrexate—bone cancer	0.00353	0.00353	CcSEcCtD
Cefotetan—Gastrointestinal pain—Epirubicin—bone cancer	0.00341	0.00341	CcSEcCtD
Cefotetan—Urticaria—Epirubicin—bone cancer	0.00332	0.00332	CcSEcCtD
Cefotetan—Abdominal pain—Epirubicin—bone cancer	0.0033	0.0033	CcSEcCtD
Cefotetan—Body temperature increased—Epirubicin—bone cancer	0.0033	0.0033	CcSEcCtD
Cefotetan—Hypersensitivity—Methotrexate—bone cancer	0.00329	0.00329	CcSEcCtD
Cefotetan—Gastrointestinal pain—Doxorubicin—bone cancer	0.00316	0.00316	CcSEcCtD
Cefotetan—Pruritus—Methotrexate—bone cancer	0.00316	0.00316	CcSEcCtD
Cefotetan—Hypersensitivity—Epirubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Cefotetan—Urticaria—Doxorubicin—bone cancer	0.00307	0.00307	CcSEcCtD
Cefotetan—Abdominal pain—Doxorubicin—bone cancer	0.00305	0.00305	CcSEcCtD
Cefotetan—Body temperature increased—Doxorubicin—bone cancer	0.00305	0.00305	CcSEcCtD
Cefotetan—Diarrhoea—Methotrexate—bone cancer	0.00305	0.00305	CcSEcCtD
Cefotetan—Pruritus—Epirubicin—bone cancer	0.00295	0.00295	CcSEcCtD
Cefotetan—Diarrhoea—Epirubicin—bone cancer	0.00286	0.00286	CcSEcCtD
Cefotetan—Hypersensitivity—Doxorubicin—bone cancer	0.00285	0.00285	CcSEcCtD
Cefotetan—Vomiting—Methotrexate—bone cancer	0.00284	0.00284	CcSEcCtD
Cefotetan—Rash—Methotrexate—bone cancer	0.00281	0.00281	CcSEcCtD
Cefotetan—Dermatitis—Methotrexate—bone cancer	0.00281	0.00281	CcSEcCtD
Cefotetan—Pruritus—Doxorubicin—bone cancer	0.00273	0.00273	CcSEcCtD
Cefotetan—Vomiting—Epirubicin—bone cancer	0.00265	0.00265	CcSEcCtD
Cefotetan—Nausea—Methotrexate—bone cancer	0.00265	0.00265	CcSEcCtD
Cefotetan—Diarrhoea—Doxorubicin—bone cancer	0.00264	0.00264	CcSEcCtD
Cefotetan—Rash—Epirubicin—bone cancer	0.00263	0.00263	CcSEcCtD
Cefotetan—Dermatitis—Epirubicin—bone cancer	0.00263	0.00263	CcSEcCtD
Cefotetan—Nausea—Epirubicin—bone cancer	0.00248	0.00248	CcSEcCtD
Cefotetan—Vomiting—Doxorubicin—bone cancer	0.00246	0.00246	CcSEcCtD
Cefotetan—Rash—Doxorubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Cefotetan—Dermatitis—Doxorubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Cefotetan—Nausea—Doxorubicin—bone cancer	0.00229	0.00229	CcSEcCtD
